$113 Million is the total value of Velan Capital Investment Management LP's 28 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 400.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $19,121,500 | – | 50,000 | +100.0% | 16.89% | – |
| OPTN | Buy | OPTINOSE INC | $6,469,193 | -18.8% | 3,496,861 | +60.7% | 5.72% | -27.7% |
| HRTX | New | HERON THERAPEUTICS INC | $6,250,000 | – | 2,500,000 | +100.0% | 5.52% | – |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $3,602,251 | – | 494,136 | +100.0% | 3.18% | – |
| INSP | New | INSPIRE MED SYS INC | $2,518,800 | – | 10,000 | +100.0% | 2.22% | – |
| THC | New | TENET HEALTHCARE CORP | $2,439,500 | – | 50,000 | +100.0% | 2.16% | – |
| CTLT | New | CATALENT INC | $2,250,500 | – | 50,000 | +100.0% | 1.99% | – |
| IMTX | New | IMMATICS N.V | $2,177,500 | – | 250,000 | +100.0% | 1.92% | – |
| EDSA | New | EDESA BIOTECH INC | $1,919,998 | – | 888,888 | +100.0% | 1.70% | – |
| SGEN | New | SEAGEN INC | $1,285,100 | – | 10,000 | +100.0% | 1.14% | – |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $1,031,194 | +61.1% | 44,448 | +11.2% | 0.91% | +43.5% |
| Buy | ALIMERA SCIENCES INC | $698,511 | -39.6% | 257,753 | +13.2% | 0.62% | -46.2% | |
| New | CONFORMIS INC | $684,770 | – | 206,256 | +100.0% | 0.60% | – | |
| CHRS | New | COHERUS BIOSCIENCES INC | $654,232 | – | 82,605 | +100.0% | 0.58% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $108,376 | – | 10,646 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
| ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
| JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
| TELA BIO INC | 8 | Q3 2023 | 7.6% |
| REZOLUTE INC | 8 | Q3 2023 | 1.3% |
| OPTINOSE INC | 7 | Q3 2023 | 7.9% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
| SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
| SC 13G/A | 2024-01-29 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-04 |
| 4 | 2023-08-17 |
| SC 13D/A | 2023-08-16 |
| 13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.